List view / Grid view
15 April 2015 | By Victoria White
Soligenix and the FDA have reached an agreement on the design of a pivotal Phase 3 trial evaluating SGX203 in the treatment of paediatric Crohn’s disease...
15 April 2015 | By Victoria White
The Phase 2 clinical trial of Imprime PGG and bevacizumab achieved meaningful reductions in tumour burden in patients with non-small cell lung cancer...
15 April 2015 | By Victoria White
The global treatment market for Duchenne Muscular Dystrophy will expand in value at a CAGR of 160.5% to $990 million by 2019, says GlobalData...
15 April 2015 | By Victoria White
The Phase 3 PALOMA-3 trial for IBRANCE has been stopped early due to efficacy seen in women with HR+, HER2- metastatic breast cancer...
15 April 2015 | By Daiichi Sankyo
Swissmedic has granted approval of Lixiana for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation...
15 April 2015 | By Victoria White
WHO has issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result...
15 April 2015 | By Victoria White
The U.S. Food and Drug Administration (FDA) has agreed to the proposed Phase 3 clinical development programme for Motif’s lead product candidate, iclaprim...
15 April 2015 | By Victoria White
The European Regulatory Authority has approved Omeros’ OMS721 for compassionate use in two patients with with thrombotic microangiopathy...
14 April 2015 | By Victoria White
Incyte's base for European clinical development operations is to be based in Geneva, Switzerland. Incyte is to occupy a 9,000 sq. ft. facility by mid-2015...
14 April 2015 | By Victoria White
Merck is introducing diabetes management training for more than 5,000 Maharashtra University students as part of the Merck Capacity Advancement Program...
14 April 2015 | By Victoria White
The Changing Diabetes in Children programme, a scheme that has provided free insulin to 13,000 children since 2009, has been extended by three years.
14 April 2015 | By Victoria
The NEFIGAN Trial of Nefecon for the treatment of primary IgA nephropathy has fully met its primary efficacy endpoint at a planned interim analysis...
14 April 2015 | By Victoria White
A new liver cancer treatment developed by the UMC Utrecht that uses uses radioactive holmium microspheres has received the European CE mark...
14 April 2015 | By Victoria White
Merck has announced that Udit Batra has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich...
13 April 2015 | By Victoria White
Ichor Medical Systems has announced that it has entered into a product development collaboration and worldwide license agreement with Janssen...
